Composites For Bone Tissue Engineering Research Articles

Gelatin Methacryloyl (GelMA) - 45S5 Bioactive Glass (BG) Composites for Bone Tissue Engineering: 3D Extrusion Printability and Cytocompatibility Assessment Using Human Osteoblasts.

3D extrusion printing has been widely investigated for low-volume production of complex-shaped scaffolds for tissue regeneration. Gelatin methacryloyl (GelMA) is used as a baseline material for the synthesis of biomaterial inks, often with organic/inorganic fillers, to obtain a balance between good printability and biophysical properties. The present study demonstrates how 45S5 bioactive glass (BG) addition and GelMA concentrations can be tailored to develop GelMA composite scaffolds with good printability and buildability. The experimental results suggest that 45S5 BG addition consistently decreases the compression stiffness, irrespective of GelMA concentration, albeit within 20% of the baseline scaffold (without 45S5 BG). The optimal addition of 2 wt % 45S5 BG in 7.5 wt % GelMA was demonstrated to provide the best combination of printability and buildability in the 3D extrusion printing route. The degradation decreases and the swelling kinetics increases with 45S5 BG addition, irrespective of GelMA concentration. Importantly, the dissolution in simulated body fluid over 3 weeks clearly promoted the nucleation and growth of crystalline calcium phosphate particles, indicating the potential of GelMA-45S5 BG to promote biomineralization. The cytocompatibility assessment using human osteoblasts could demonstrate uncompromised cell proliferation or osteogenic marker expression over 21 days in culture for 3D printable 7.5 wt % GelMA -2 wt % 45S5 BG scaffolds when compared to 7.5 wt % GelMA. The results thus encourage further investigations of the GelMA/45S5 BG composite system for bone tissue engineering applications.

Entropically Toughened Robust Biodegradable Polymer Blends and Composites for Bone Tissue Engineering.

Biodegradable polymers and composites are promising candidates for biomedical implants in tissue engineering. However, state-of-the-art composite scaffolds suffer from a strength-toughness dilemma due to poor interfacial adhesion and filler dispersion. In this work, we propose a facile and scalable strategy to fabricate strong and tough biocomposite scaffolds through interfacial toughening. The immiscible biopolymer matrix is compatible by the direct incorporation of a third polymer. Densely entangled polymer chains lead to massive crazes and global shear yields under tension. Weak chemical interaction and high-shear melt processing create nanoscale dispersion of nanofillers within the matrix. The resultant ternary blends and composites exhibit an 11-fold increase in toughness without compromising stiffness and strength. At 70% porosity, three-dimensional (3D)-printed composite scaffolds demonstrate high compressive properties comparable to those of cancellous bones. In vitro cell culture on the scaffolds demonstrates not only good cell viability but also effective osteogenic differentiation of human mesenchymal stem cells. Our findings present a widely applicable strategy to develop high-performance biocomposite materials for tissue regeneration.

Sodium alginate/hydroxyapatite/graphene nanoplatelets composites for bone tissue engineering

Sodium alginate/hydroxyapatite/graphene nanoplatelets composites for bone tissue engineering

Dissolution-precipitation synthesis and cold sintering of mussel shells-derived hydroxyapatite and hydroxyapatite/chitosan composites for bone tissue engineering

In the present work, seafood by-products and derivates were exploited as raw materials to produce nanocrystalline calcium phosphates-based composites in light of the rising demand for waste recovery and valorisation. Mussel shells were transformed into hydroxyapatite by dissolution-precipitation synthesis at 45 °C, whereas chitosan from shrimp shells was introduced as a reinforcing biopolymer to produce hydroxyapatite/chitosan composites. The synthesised hydroxyapatite and hydroxyapatite/chitosan composite powders were cold sintered at room temperature under 1 GPa pressure for 10 min. The materials were consolidated up to ∼90% relative density and characterized mechanically. By increasing the polymer content up to 10 wt%, the flexural strength of the sintered pellets increases from ∼45 MPa to ∼57 MPa while the hardness decreases from ∼1.1 GPa to ∼0.8 GPa, thus better addressing the mechanical properties of cortical bone. Furthermore, hydroxyapatite/chitosan composites were proven to be bioactive, this demonstrating their potential use in bone tissue engineering applications.

Effect of filler size distribution on the mechanical and biological properties of biomimetic bone composites fabricated by solvent-based extrusion bioprinting

Biomimetic composites for bone tissue engineering have outstanding potential to improve bone grafting and in vitro drug testing. Although bioactive fillers play a crucial role in those composites, the impact of their physical properties on final products is not fully understood, particularly when using solvent-based extrusion bioprinting (SBEB). In our study, we used ball-milled bioactive glass and hydroxyapatite powders to examine how particle size distribution impacts the flow, mechanical, and biological properties of biomaterials produced via SBEB. The polymeric matrix of polycaprolactone (PCL) was dissolved in solvents, and the fillers were mixed in different proportions to optimize the biomaterial ink's extrudability and interphase bonding. The printed samples were subjected to mechanical testing, solvent removal, and cytotoxicity analysis. Our results show that powders milled at 25 Hz for 10 min in a dry medium produced homogeneous size distributions with low agglomeration. A 50% PCL and 50% w/w polymer-to-filler ratio in an 80% w/v solid–liquid proportion generated the best extrudability and interphase bonding. Particle type affected the modulus of elasticity, and smaller aggregate sizes increased ultimate tensile strength. Moreover, the specific size of the filler particles and their structure could influence their affinity to solvents, thereby resulting in variation in the solvent removal process after ethanol rinsing. Beyond that, the biomaterials were non-cytotoxic and demonstrated high cell viability. Those findings highlight the importance of controlling the filler size distribution to optimize the mechanical, rheological, and biological properties of biomaterials fabricated using SBEB for bone tissue engineering applications.

Comparison of bovine serum albumin and chitosan effects on calcium phosphate formation in the presence of silver nanoparticles.

The precipitation of calcium phosphates (CaPs) in the presence of more than one type of additive is of interest both from a fundamental point of view and as a possible biomimetic route for the preparation of multicomponent composites in which the activity of the components is preserved. In this study, the effect of bovine serum albumin (BSA) and chitosan (Chi) on the precipitation of CaPs in the presence of silver nanoparticles (AgNPs) stabilized with sodium bis(2-ethylhexyl)sulfosuccinate (AOT-AgNPs), poly(vinylpyrrolidone) (PVP-AgNPs), and citrate (cit-AgNPs) was investigated. In the control system, the precipitation of CaPs occurred in two steps. Amorphous calcium phosphate (ACP) was the first precipitated solid, which transformed into a mixture of calcium-deficient hydroxyapatite (CaDHA) and a smaller amount of octacalcium phosphate (OCP) after 60 min of ageing. Both biomacromolecules inhibited ACP transformation, with Chi being a stronger inhibitor due to its flexible molecular structure. As the concentration of the biomacromolecules increased, the amount of OCP decreased both in the absence and presence of AgNPs. In the presence of cit-AgNPs and two highest BSA concentrations, a change in the composition of the crystalline phase was observed. Calcium hydrogen phosphate dihydrate was formed in the mixture with CaDHA. An effect on the morphology of both the amorphous and crystalline phases was observed. The effect depended on the specific combination of biomacromolecules and differently stabilized AgNP. The results obtained suggest a simple method for fine-tuning the properties of precipitates using different classes of additives. This could be of interest for the biomimetic preparation of multifunctional composites for bone tissue engineering.

Fabrication of novel multilayer core-shell structured nanofibers network reinforced carbon matrix composites for bone tissue engineering

To further optimize the structure of bone tissue engineering composites, silicon nitride nanowires-pyrolytic carbon-hydroxyapatite-carbon matrix (Si3N4nws@PyCnls-HA-C) composites with multilayer core–shell structures are synthesized by chemical vapor deposition (CVD), pulsed electrodeposition (PED), and chemical vapor infiltration (CVI) methods. The microstructure, in-vitro bioactivity, and in-vivo histocompatibility of Si3N4nws@PyCnls-HA-C (SPHC) composites are evaluated. In-vitro, the SPHC exhibited a cell proliferation rate of 157.7% and demonstrated outstanding protein adsorption. In-vivo, the SPHC demonstrated excellent histocompatibility. Therefore, the SPHC composites can serve as an alternative suitable biomaterial for bone tissue engineering.

Laser powder bed fusion of ultra-high-molecular-weight polyethylene/hydroxyapatite composites for bone tissue engineering

Laser powder bed fusion also known as selective laser sintering (SLS) or selective laser melting (SLM) has been proved to be a valuable manufacturing technique for implantable devices . Polymeric/ceramic biocomposites emerge as favourable materials for fabricating customized implants targeting bone tissue applications. However, improvements in processability and properties are still required. This work has investigated the use of different amounts of spray-dried hydroxyapatite (SDHA) particles in a polymeric matrix of ultra-high-molecular-weight polyethylene (UHMWPE), varying SLS processing parameters. Powder characteristics were assessed, the dimensional and mechanical properties of samples were measured, and preliminary in vitro assays were conducted. Biological results demonstrated the biocompatibility of the SLS fabricated samples, not inhibiting cell growth and supporting pre-osteoblast attachment. Nevertheless, a greater amount of SDHA has hindered the mechanical properties of samples, so a compromise must be found. • Assessment of SDHA and UHMWPE powder mixture for laser powder bed fusion process. • SDHA particles added to UHMWPE have facilitated the particle flow. • In vitro assays have shown that the fabricated samples are biocompatible. • SDHA can improve biological response but decreases mechanical properties.

Chitosan‐Based Porous Composites for Bone Tissue Engineering

AbstractThis paper highlights the idea of creating highly porous composite materials for osteogenesis purposes based on chitosan with various functional fillers: reduced graphene oxide (rGO) and tricalcium phosphate (TCP). RGO filler is a carbon based electrical conductor with a high aspect ratio, therefore it is preferred for growth of osteoblasts populations with concomitant electrical stimulation. TCP is the main building block of bone tissue; hence composites filled with it can be used to accelerate the process of osteosynthesis. This paper considers the aspects of the functional agents influence on the morphological, electrically conductive, and mechanical characteristics of composites based on chitosan.

Biodegradable polyphosphazene – hydroxyapatite composites for bone tissue engineering

The venture to fabricate potential and functional bone regeneration, annihilating the health complexities in conventional bone grafting, made Bone tissue engineering (BTE), which facilitates meticulous control of the spatial and temporal dissemination of cells and extracellular matrix (ECM), receive incredible consideration in the past few years. Ascribable to their exceptional properties, polymers have gotten significant attention as one of the prominent classes of biomaterials for BTE. The compatible mechanical properties, biocompatibility, bioactivity, and biodegradability of polyphosphazene/hydroxyapatite composite made them candidates for functional bone regeneration. This review demonstrates the synthesis, properties, and application of polyphosphazenes, hydroxyapatite, and composite biomaterial for BTE.

Novel Trends into the Development of Natural Hydroxyapatite-Based Polymeric Composites for Bone Tissue Engineering.

In recent years, the number of people needing bone replacements for the treatment of defects caused by chronic diseases or accidents has continuously increased. To solve these problems, tissue engineering has gained significant attention in the biomedical field, by focusing on the development of suitable materials that improve osseointegration and biologic activity. In this direction, the development of an ideal material that provides good osseointegration, increased antimicrobial activity and preserves good mechanical properties has been the main challenge. Currently, bone tissue engineering focuses on the development of materials with tailorable properties, by combining polymers and ceramics to meet the necessary complex requirements. This study presents the main polymers applied in tissue engineering, considering their advantages and drawbacks. Considering the potential disadvantages of polymers, improving the applicability of the material and the combination with a ceramic material is the optimum pathway to increase the mechanical stability and mineralization process. Thus, ceramic materials obtained from natural sources (e.g., hydroxyapatite) are preferred to improve bioactivity, due to their similarity to the native hydroxyapatite found in the composition of human bone.

Tough Photo-Cross-Linked PCL-Hydroxyapatite Composites for Bone Tissue Engineering.

Acrylate-based photo-cross-linked poly(ε-caprolactone) (PCL) tends to show low elongation and strength. Incorporation of osteo-inductive hydroxyapatite (HAp) further enhances this effect, which limits its applicability in bone tissue engineering. To overcome this, the thiol-ene click reaction is introduced for the first time in order to photo-cross-link PCL composites with 0, 10, 20, and 30 wt % HAp nanoparticles. It is demonstrated that the elongation at break and ultimate strength increase 10- and 2-fold, respectively, when the photopolymerization mechanism is shifted from a radical chain-growth (i.e., acrylate cross-linking) toward a radical step-growth polymerization (i.e., thiol-ene cross-linking). Additionally, it is illustrated that osteoblasts can attach to and proliferate on the surface of the photo-cross-linked PCL-HAp composites. Finally, the incorporation of HAp nanoparticles is shown to reduce the ALP activity of osteoblasts. Overall, thiol-ene cross-linked PCL-HAp composites can be considered as promising potential materials for bone tissue engineering.

Critical Review of Biodegradable and Bioactive Polymer Composites for Bone Tissue Engineering and Drug Delivery Applications.

In the determination of the bioavailability of drugs administered orally, the drugs’ solubility and permeability play a crucial role. For absorption of drug molecules and production of a pharmacological response, solubility is an important parameter that defines the concentration of the drug in systemic circulation. It is a challenging task to improve the oral bioavailability of drugs that have poor water solubility. Most drug molecules are either poorly soluble or insoluble in aqueous environments. Polymer nanocomposites are combinations of two or more different materials that possess unique characteristics and are fused together with sufficient energy in such a manner that the resultant material will have the best properties of both materials. These polymeric materials (biodegradable and other naturally bioactive polymers) are comprised of nanosized particles in a composition of other materials. A systematic search was carried out on Web of Science and SCOPUS using different keywords, and 485 records were found. After the screening and eligibility process, 88 journal articles were found to be eligible, and hence selected to be reviewed and analyzed. Biocompatible and biodegradable materials have emerged in the manufacture of therapeutic and pharmacologic devices, such as impermanent implantation and 3D scaffolds for tissue regeneration and biomedical applications. Substantial effort has been made in the usage of bio-based polymers for potential pharmacologic and biomedical purposes, including targeted deliveries and drug carriers for regulated drug release. These implementations necessitate unique physicochemical and pharmacokinetic, microbiological, metabolic, and degradation characteristics of the materials in order to provide prolific therapeutic treatments. As a result, a broadly diverse spectrum of natural or artificially synthesized polymers capable of enzymatic hydrolysis, hydrolyzing, or enzyme decomposition are being explored for biomedical purposes. This summary examines the contemporary status of biodegradable naturally and synthetically derived polymers for biomedical fields, such as tissue engineering, regenerative medicine, bioengineering, targeted drug discovery and delivery, implantation, and wound repair and healing. This review presents an insight into a number of the commonly used tissue engineering applications, including drug delivery carrier systems, demonstrated in the recent findings. Due to the inherent remarkable properties of biodegradable and bioactive polymers, such as their antimicrobial, antitumor, anti-inflammatory, and anticancer activities, certain materials have gained significant interest in recent years. These systems are also actively being researched to improve therapeutic activity and mitigate adverse consequences. In this article, we also present the main drug delivery systems reported in the literature and the main methods available to impregnate the polymeric scaffolds with drugs, their properties, and their respective benefits for tissue engineering.

Development of carboxymethylcellulose based composites for bone tissue engineering

The present study focuses on the development of carboxymethylcellulose (CMC)–biphasic calcium phosphate (BCP) composite scaffolds through the freeze-drying process for bone tissue engineering applications. Citric acid or fumaric acid was added as the cross-linker of CMC to improve the stability of composite scaffolds. The effect of change in freezing temperature (−20, −40 or −80°C) on the pore morphology, swelling ability and mechanical properties of composite scaffolds was studied. Cross-linked scaffolds showed an increased thermal degradation temperature compared with non-cross-linked scaffolds. All the composite scaffolds showed a porous structure with homogeneous blending of CMC and BCP. Cross-linked scaffolds showed appreciable swelling ability and stability in phosphate-buffered saline, while non-cross-linked scaffolds were unstable for 24 h. Cross-linked scaffolds had lower compressive strength than non-cross-linked scaffolds under dry conditions. However, in the hydrated state, only citric acid-cross-linked scaffolds were stable with improved compressive strength of 64 ± 4, 57 ± 4 and 67 ± 4 kPa when processed at −20, −40 and −80°C, respectively. Furthermore, three-dimensional culture of Saos-2 cells on citric acid-cross-linked scaffolds showed their suitability for cell proliferation and osteogenic differentiation. Therefore, citric acid-cross-linked CMC–BCP composite scaffolds may be promising scaffolds for bone tissue engineering applications.

Mechanical, Structural, and Biological Properties of Chitosan/Hydroxyapatite/Silica Composites for Bone Tissue Engineering.

The aim of this work was to fabricate novel bioactive composites based on chitosan and non-organic silica, reinforced with calcium β-glycerophosphate (Ca-GP), sodium β-glycerophosphate pentahydrate (Na-GP), and hydroxyapatite powder (HAp) in a range of concentrations using the sol–gel method. The effect of HAp, Na-GP, and Ca-GP contents on the mechanical properties, i.e., Young’s modulus, compressive strength, and yield strain, of hybrid composites was analyzed. The microstructure of the materials obtained was visualized by SEM. Moreover, the molecular interactions according to FTIR analysis and biocompatibility of composites obtained were examined. The CS/Si/HAp/Ca-GP developed from all composites analyzed was characterized by the well-developed surface of pores of two sizes: large ones of 100 μm and many smaller pores below 10 µm, the behavior of which positively influenced cell proliferation and growth, as well as compressive strength in a range of 0.3 to 10 MPa, Young’s modulus from 5.2 to 100 MPa, and volumetric shrinkage below 60%. This proved to be a promising composite for applications in tissue engineering, e.g., filling small bone defects.

Biomechanical Evaluation of an Injectable Alginate / Dicalcium Phosphate Cement Composites for Bone Tissue Engineering

Biocompatible dicalcium phosphate (DCP) cements are widely used as bone repair materials. In this study, we aimed to investigate the impact of different amounts of sodium alginate (SA) on the microstructural, mechanical, and biological properties of DCP cements. Beta-tricalcium phosphate (β-TCP) was prepared using a microwave-assisted wet precipitation system. Lattice parameters of the obtained particles determined from X-ray diffraction (XRD), were in good match with a standard phase of β-TCP. Scanning electron microscopy (SEM) examination revealed that the particles were in globular shape. Furthermore, all functional groups of β-TCP were also detected using Fourier-transform infrared spectroscopy (FTIR) spectra. DCP cement (pure phase) was synthesized using monocalcium phosphate monohydrate (MCPM)/β-TCP powder mixture blended with 1.0 mL of water. SA/DCP cement composites were synthesized by dissolving different amounts of SA into water (1.0 mL) to obtain different final concentrations (0.5%, 1%, 2% and 3%). The prepared cements were characterized with XRD, SEM, FTIR and Thermogravimetric analysis (TGA). XRD results showed that pure DCP and SA/DCP cements were in a good match with Monetite phase. SEM results confirmed that addition of SA inhibited the growth of DCP particles. Setting time and injectability behaviour were significantly improved upon increasing the SA amount into DCP cements. In vitro biodegradation was evaluated using Simulated body fluid (SBF) over 21 days at 37 °C. The highest cumulative weight loss (%) in SBF was observed for 2.0% SA/DCP (about 26.52%) after 21 days of incubation. Amount of Ca2+ ions released in SBF increased with the addition of SA. DCP and SA/DCP cements showed the highest mechanical strength after 3 days of incubation in SBF and declined with prolonged immersion periods. In vitro cell culture experiments were conducted using Dental pulp stem cells (DPSCs). Viability and morphology of cells incubated in extract media of DCP and SA/DCP discs after 24 h incubation was studied with MTT assay and fluorescence microscopy imaging, respectively. All cements were cytocompatible and viability of cells incubated in extracts of cements was higher than observed in the control group. Based on the outcomes, SA/DCP bone cements have a promising future to be utilized as bone filler.

An assessment of alginate composites for bone tissue engineering

An assessment of alginate composites for bone tissue engineering

FDM 3D Printed Composites for Bone Tissue Engineering Based on Plasticized Poly(3-hydroxybutyrate)/poly(d,l-lactide) Blends.

Tissue engineering is a current trend in the regenerative medicine putting pressure on scientists to develop highly functional materials and methods for scaffolds’ preparation. In this paper, the calibrated filaments for Fused Deposition Modeling (FDM) based on plasticized poly(3-hydroxybutyrate)/poly(d,l-lactide) 70/30 blend modified with tricalcium phosphate bioceramics were prepared. Two different plasticizers, Citroflex (n-Butyryl tri-n-hexyl citrate) and Syncroflex (oligomeric adipate ester), both used in the amount of 12 wt%, were compared. The printing parameters for these materials were optimized and the printability was evaluated by recently published warping test. The samples were studied with respect to their thermal and mechanical properties, followed by biological in vitro tests including proliferation, viability, and osteogenic differentiation of human mesenchymal stem cells. According to the results from differential scanning calorimetry and tensile measurements, the Citroflex-based plasticizer showed very good softening effect at the expense of worse printability and unsatisfactory performance during biological testing. On the other hand, the samples with Syncroflex demonstrated lower warping tendency compared to commercial polylactide filament with the warping coefficient one third lower. Moreover, the Syncroflex-based samples exhibited the non-cytotoxicity and promising biocompatibility.

Редкий случай гиподисфибриногенемии у пациента без гематомезенхимальной дисплазии

Фибриноген и коллаген являются важнейшими протеинами межклеточного матрикса, оказывающие прямое влияние как на дифференцировку мезенхимальных стволовых клеток, так и на остеогенез. Кроме того, в клинической практике встречаются случаи протекания данного синдрома не в классическом виде, которые требуют более углубленного изучения звеньев патогенеза и разработки оптимальной коррекции заболевания. Нами проведен поиск литературных данных по ключевым словам в базах данных PubMed, UpToDate, BMJ. Представлен обзор современных научных данных и результаты наблюдения редкого клинического случая у пациента с гиподисфибриногенемией с проявлениями асептического некроза головок бедренных костей без гематомезенхимальной дисплазии. Заключение: В целом, в настоящее время подробно изучены различные аспекты клинико-биохимического патогенеза аномалий фибриногена, но остаются «белые пятна» в изучении тонких патогенетических механизмов на молекулярно-генетическом уровне, а именно: катаболизм белка, реакции раздельного синтеза отдельных полипептидных цепей фибриногена в разных тканях. Остается нерешенным вопрос о целесообразности применения корригирующих гемостаз препаратов таргетного действия при отсутствии у пациента выраженных тромботических и геморрагических проявлений. Fibrinogen and collagen are the most important intercellular matrix proteins that directly effect on the differentiation of mesenchymal stem cells and osteogenesis. In addition, there are non-classical cases of this syndrome that require indepth study of pathogenesis and optimal disease correction. We examined literature data by keywords in databases PubMed, UpToDate, BMJ. We presented a review of current scientific data and observation results of a rare clinical case in a patient with hypodysfibrinogenemia without hematomesenchymal dysplasia with manifestations of aseptic necrosis of femoral heads. Conclusions: In general, various aspects of clinical and biochemical pathogenesis of fibrinogen abnormalities are currently studied in detail, but there are “white spots” in the study of sophisticated pathogenetic mechanisms at the molecular genetic level, namely protein catabolism, the reaction of separate synthesis of individual fibrinogen polypeptide chains in different tissues. Unresolved is the question of applicability of hemostatic corrective drugs in the absence of expressed thrombotic and hemorrhagic manifestations.

Antibacterial alginate/nano-hydroxyapatite composites for bone tissue engineering: Assessment of their bioactivity, biocompatibility, and antibacterial activity.

Bone substitute materials based on bioceramics and polymers have evolved shifting from a passive role where they are merely accepted by the body; to an active role, where they respond to particular environmental conditions or to different types of cues generating suitable integration (osseointegration for this case) inside the host tissue. In this work, two types of composite materials based on a bioceramic (synthetic nano-hydroxyapatite, HA) and a biopolymer (sodium alginate, ALG) have been designed and assessed for promoting the bone regeneration. These materials were loaded with ciprofloxacin (CIP) for obtaining, not only a suitable material for a filling but with antibacterial properties. Therefore, their main features were studied through Fourier transformed-infrared spectroscopy (FT-IR), X-ray diffraction (XRD) and transmission electron microscopy (TEM). Ultraviolet-Visible (UV-Vis) spectroscopy was used for obtaining the released concentrations of CIP and Zeta-potential (ζ-potential) was used for characterizing the adsorption of CIP onto nanoparticles. The release profile of this drug has been fit with the Ritger-Peppas model, used for studying the release kinetics of hydrogel-based systems. The bioactivity of these composites was also evaluated after 30days of incubation in a simulated body fluid solution (SBF). Then, the assessment of antibacterial capability against the three main strains cause osteomyelitis was performed. Finally, the cell viability study and the cellular morphology assay were also carried out. These last assays have shown encouraging results and, gathered with their other properties, such as their bioactivity and antibacterial properties; they could lead to propose these materials as new bone filler antibiotic devices.